logo
AAT Bioquest

ReadiPrep™ PEG Virus Precipitation Kit

Product key features

ReadiPrep™ PEG Virus Precipitation Kit delivers high-efficiency virus concentration with safe and user-friendly handling.

  • Efficient concentration: Achieves over 100-fold increase in viral concentration without ultracentrifugation
  • Applications: Ideal for infection assays, viral nucleic acid purification, and general virology research
  • Optimized recovery: Improves viral yield by 40 to 100% with the included Virus Resuspension Solution
  • Comparable alternative: Provides an efficient option similar to commercial PEG virus precipitation kit from Thermo Fisher

Product description

The ReadiPrep™ PEG Virus Precipitation Kit provides a fast, efficient, and safe method for concentrating viral particles without the need for ultracentrifugation. Using a PEG-based precipitation approach, this kit can increase viral concentration by more than 100-fold from cell culture media or environmental samples, making it suitable for both small-scale preparations with low titers and large-scale virus production. The included optimized ReadiPrep™ Virus Resuspension Solution enhances viral recovery by 40 to 100%, depending on virus type and source.

Designed for versatility, the kit is compatible with retroviruses, baculoviruses, lentiviruses, and phages. It uses only non-toxic reagents, allowing for safer handling and minimizing the risk of hazardous exposure. The concentrated virus is ready for use in downstream applications, including infection assays, viral nucleic acid extraction, and a range of virology research workflows.

Example protocol

SAMPLE EXPERIMENTAL PROTOCOL

Important Note

The procedure is designed for 10 mL of virus solution, but one can adjust the volumes proportionally based on the sample size.

  1. Infect cells or transfect cells, and allow maximum virus accumulation.

  2. For mammalian cell-virus or insect-baculovirus, centrifuge culture at 3,200 X g (for bacterial phage, centrifuge at 16,000 X g) for 15 minutes at 4 °C to remove cell debris.

  3. Collect supernatant, and add 2.5 mL of ReadiPrep™ 5X PEG Solution (Component A) to 10 mL of virus supernatant.

  4. Refrigerate overnight (stable up to 2 days at 4 °C).

  5. Centrifuge at 3,200 X g for 30 minutes at 4 °C.

  6. Remove and discard the supernatant by aspiration carefully. The beige or white pellet is the virus.

  7. Add 100 uL of ReadiPrep™ Virus Resuspension Solution (Component B) to the virus pellet, and mix well.

  8. Aliquot the virus and store it at < –70 °C for future use.

    Note: For a high-titer virus preparation, the resuspension volume should be limited to about three times the volume of the white pellet, usually 1/10 to 1/100 the volume of the original sample. If insoluble material is present in the viral suspension, it can be removed by centrifuge at 3,200 x g for 15 min at +4 °C.

    Note: Avoid freeze/thaw cycles to maximize virus recovery.

    Note: Trace amounts of PEG in the virus suspension will not affect the use of the concentrated virus. In some cases, PEG may increase virus infection efficiency. However, if it is desired, the trace amount of PEG can be removed by the following procedure:

    1. Add 1 volume of solution containing 4 M KCl and 50 mM Tris-HCl, pH 7.2 (not provided), to 3 volumes of the concentrated virus suspension.  Alternatively, add solid KCl into the virus suspension to a final concentration of 1 M.

    2. Let stand on ice for 15–30 minutes. Then, spin at 12,000 x g for 10 min at 4 °C to remove the precipitate.

    3. Collect the virus supernatant carefully. And aliquot and store at < –70° C for future use.

References

View all 16 references: Citation Explorer
Preparation, Purification and Performance Evaluation of Polyclonal Antibody Against SARS-CoV-2 Produced in Rat.
Authors: Yaghoobizadeh, Fatemeh and Roayaei Ardakani, Mohammad and Ranjbar, Mohammad Mehdi and Khosravi, Mohammad and Galehdari, Hamid
Journal: Advanced pharmaceutical bulletin (2023): 563-572
Comparison of the methods for isolation and detection of SARS-CoV-2 RNA in municipal wastewater.
Authors: Lucansky, Vincent and Samec, Marek and Burjanivova, Tatiana and Lukacova, Eva and Kolkova, Zuzana and Holubekova, Veronika and Turyova, Eva and Hornakova, Andrea and Zaborsky, Tibor and Podlesniy, Petar and Reizigova, Lenka and Dankova, Zuzana and Novakova, Elena and Pecova, Renata and Calkovska, Andrea and Halasova, Erika
Journal: Frontiers in public health (2023): 1116636
Concentration of infectious SARS-CoV-2 by polyethylene glycol precipitation.
Authors: Alexander, Marina R and Rootes, Christina L and van Vuren, Petrus Jansen and Stewart, Cameron R
Journal: Journal of virological methods (2020): 113977
Creation of a High-Yield AAV Vector Production Platform in Suspension Cells Using a Design-of-Experiment Approach.
Authors: Zhao, Huiren and Lee, Ki-Jeong and Daris, Mark and Lin, Yun and Wolfe, Thomas and Sheng, Jackie and Plewa, Cherylene and Wang, Songli and Meisen, W Hans
Journal: Molecular therapy. Methods & clinical development (2020): 312-320
Characterization of rVSVΔG-ZEBOV-GP glycoproteins using automated capillary western blotting.
Authors: Minsker, Kevin and Rustandi, Richard R and Ha, Sha and Loughney, John W
Journal: Vaccine (2020): 7166-7174
Page updated on August 22, 2025

Ordering information

Price
Unit size
40 Preparations
160 Preparations
Catalog Number
6020260203
Quantity
Add to cart

Additional ordering information

Telephone1-800-990-8053
Fax1-800-609-2943
Emailsales@aatbio.com
InternationalSee distributors
Bulk requestInquire
Custom sizeInquire
Technical SupportContact us
Purchase orderSend to sales@aatbio.com
ShippingStandard overnight for United States, inquire for international
Request quotation

Storage, safety and handling

H-phraseH303, H313, H333
Hazard symbolXN
Intended useResearch Use Only (RUO)
R-phraseR20, R21, R22

Storage

Freeze (< -15 °C); Minimize light exposure
UNSPSC12352200

Components